Related Experiment Videos
[Autoantibodies in children with vitiligo]
Sonja Prćić1, Verica Duran, Mirjana Poljacki
1Institut za zdravstvenu zastitu dece i omladine, Medicinski fakultet, Novi Sad. buki97@Eunet.yu
Medicinski Pregled
|January 1, 2005
Summary
Children with vitiligo showed no significant increase in autoantibodies (AT) or associated autoimmune diseases compared to healthy children. However, adults with vitiligo had a higher incidence of these conditions, supporting previous findings.
Area of Science:
- Dermatology
- Immunology
- Pediatrics
Context:
- Vitiligo is a skin depigmentation disorder that can be familial and often manifests before age twenty.
- Investigating autoimmune markers and associated diseases in pediatric vitiligo is crucial for understanding disease progression and potential comorbidities.
Purpose:
- To determine the incidence and significance of autoantibodies (AT) and associated autoimmune/endocrine diseases in children with vitiligo.
- To compare these findings with control groups of children and adults with vitiligo.
Summary:
- The study found that children with vitiligo did not exhibit a significant increase in autoantibodies (antinuclear, antithyroid, anti-gastric parietal cell, anti-smooth muscle, anti-cord, or anti-mitochondrial) compared to age-matched controls.
- Unlike adults with vitiligo, none of the children in the study presented with associated autoimmune or endocrine diseases.
- A positive family history of vitiligo was more common in children with the condition.
Impact:
- This research suggests that pediatric vitiligo may have a different autoimmune profile than adult vitiligo.
- Findings indicate that routine screening for autoimmune and endocrine diseases might not be as critical in children with vitiligo compared to adults.
- Further research is needed to fully elucidate the autoimmune associations in pediatric vitiligo.